Disparities in OUD treatment: Buprenorphine vs. naltrexone
Understanding disparities in opioid use disorder (OUD) treatment Pharmaceutical companies committed...
Topic
Case Studies
How Amgen & HealthVerity found treatment gaps in high-risk diabetes care
Amgen’s new retrospective study, VESALIUS-REAL, examines how lipid-lowering therapy (LLT) is being...
Gilead uses HealthVerity data to find liver-protective treatment
Antiretroviral therapy (ART) has transformed outcomes for people living with HIV, especially those...
Who's missing out? The truth behind food allergy treatment approvals
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs)...
J&J's real-world bladder cancer study started in HealthVerity Marketplace
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
How government agencies use HealthVerity for public health and AI-powered research
Government health agencies are increasingly turning to real-world data (RWD) for public health...
HealthVerity real-world data supports CDC study on HIV PrEP surveillance
A new peer-reviewed study from the Centers for Disease Control and Prevention (CDC) highlights the...
Link between prostate cancer, mental health: The importance of real-world insights
Prostate cancer is the most common cancer among men, aside from skin cancer, and is known for being...
What everyone’s missing about data quality for AI and FDA readiness
FDA's AI guidance is reshaping real-world data standards Artificial Intelligence (AI) is rapidly...
Real-world evidence is only as strong as its data provenance
Traditional data aggregators are not enough The pharmaceutical industry is hitting a wall. Data...